These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

234 related articles for article (PubMed ID: 20437119)

  • 21. High risk of osteopenia and bone derangement in postsurgical patients with craniopharyngiomas, pituitary adenomas and other parasellar lesions.
    Okinaga H; Matsuno A; Okazaki R
    Endocr J; 2005 Dec; 52(6):751-6. PubMed ID: 16410668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Bone loss induced by cancer treatment and its management.
    Delmas PD; Fontana A
    Eur J Cancer; 1998 Feb; 34(2):260-2. PubMed ID: 9741330
    [No Abstract]   [Full Text] [Related]  

  • 23. [Cancer treatment-induced bone loss. Treatment for breast cancer].
    Yamada K; Kohno N
    Clin Calcium; 2008 Apr; 18(4):507-17. PubMed ID: 18379033
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A controlled trial of calcitonin therapy for the prevention of post-liver transplantation atraumatic fractures in patients with primary biliary cirrhosis and primary sclerosing cholangitis.
    Hay JE; Malinchoc M; Dickson ER
    J Hepatol; 2001 Feb; 34(2):292-8. PubMed ID: 11281559
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bone health in patients with brain tumors.
    Da Silva AN; Heras-Herzig A; Schiff D
    Surg Neurol; 2007 Nov; 68(5):525-33; discussion 533. PubMed ID: 17825381
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myelosuppressive therapies significantly increase pro-inflammatory cytokines and directly cause bone loss.
    Quach JM; Askmyr M; Jovic T; Baker EK; Walsh NC; Harrison SJ; Neeson P; Ritchie D; Ebeling PR; Purton LE
    J Bone Miner Res; 2015 May; 30(5):886-97. PubMed ID: 25418357
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Osteopenia and osteoporosis in women with breast cancer.
    Ramaswamy B; Shapiro CL
    Semin Oncol; 2003 Dec; 30(6):763-75. PubMed ID: 14663777
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Metabolic Bone Disease in Primary Biliary Cirrhosis.
    Glass LM; Su GL
    Gastroenterol Clin North Am; 2016 Jun; 45(2):333-43. PubMed ID: 27261902
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Bone loss and fracture risk associated with cancer therapy.
    Guise TA
    Oncologist; 2006; 11(10):1121-31. PubMed ID: 17110632
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bone health in adult cancer survivorship.
    Lustberg MB; Reinbolt RE; Shapiro CL
    J Clin Oncol; 2012 Oct; 30(30):3665-74. PubMed ID: 23008309
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
    Gnant M; Dubsky P; Fitzal F; Blaha P; Schoppmann S; Steger G; Marth C; Samonigg H; Hüttner K; Fohler H; Ruecklinger E; Jakesz R; Greil R;
    Clin Breast Cancer; 2009 Jun; 9 Suppl 1():S18-27. PubMed ID: 19561003
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Secondary skeletal involvement in Sanfilippo syndrome.
    Rigante D; Caradonna P
    QJM; 2004 Apr; 97(4):205-9. PubMed ID: 15028850
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Combined therapies of bone disease with bisphosphonates.
    Syddall SP; Ottewell PD; Holen I
    Curr Pharm Des; 2010; 16(27):2988-97. PubMed ID: 20722617
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Screening, prevention, detection, and treatment of cancer therapy-induced bone loss in patients with breast cancer.
    Limburg CE
    Oncol Nurs Forum; 2007 Jan; 34(1):55-63. PubMed ID: 17562633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mechanisms of bone loss following allogeneic and autologous hemopoietic stem cell transplantation.
    Ebeling PR; Thomas DM; Erbas B; Hopper JL; Szer J; Grigg AP
    J Bone Miner Res; 1999 Mar; 14(3):342-50. PubMed ID: 10027899
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Errors in bone remodeling: toward a unified theory of metabolic bone disease.
    Burr DB; Martin RB
    Am J Anat; 1989 Oct; 186(2):186-216. PubMed ID: 2683714
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Influence of anitiretroviral therapy on bone tissue metabolism in patients with HIV].
    Olczak A; Pawłowska M; Drózdz W
    Przegl Epidemiol; 2008; 62(1):155-62. PubMed ID: 18536239
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cancer-treatment-induced bone loss, part 1.
    Michaud LB; Goodin S
    Am J Health Syst Pharm; 2006 Mar; 63(5):419-30. PubMed ID: 16484516
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Denosumab for cancer-related bone loss.
    Dell'Aquila E; Armento G; Iuliani M; Simonetti S; D'Onofrio L; Zeppola T; Madaudo C; Russano M; Citarella F; Ribelli G; Pantano F; Vincenzi B; Tonini G; Santini D
    Expert Opin Biol Ther; 2020 Nov; 20(11):1261-1274. PubMed ID: 32835531
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bone mineral density in survivors of childhood brain tumours.
    Petraroli M; D'Alessio E; Ausili E; Barini A; Caradonna P; Riccardi R; Caldarelli M; Rossodivita A
    Childs Nerv Syst; 2007 Jan; 23(1):59-65. PubMed ID: 17058089
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.